Autophagy: Shaping the tumor microenvironment and therapeutic response

Trends in Molecular Medicine

Volumn 19, Issue 7, 2013, Pages 428-446

  Maes, Hannelore ^a   Rubio, Noemí ^a   Garg, Abhishek D ^a   Agostinis, Patrizia ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

anticancer therapy; antitumor immunity; autophagy; cancer; chloroquine.; tumor stroma

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL SURVIVAL; HUMAN; IMMUNOSURVEILLANCE; LYSOSOME; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; REVIEW; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL COMMUNICATION; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84879780600     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.04.005     Document Type: Review

References (162)

1. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
2. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
3. Rubinsztein D.C., et al. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11:709-730.
4. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
5. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
6. Wojtkowiak J.W., et al. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res. 2012, 72:3938-3947.
7. Amaravadi R.K., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
8. Chen N., Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther. 2011, 11:157-168.
9. Liu E.Y., Ryan K.M. Autophagy and cancer - issues we need to digest. J. Cell Sci. 2012, 125:2349-2358.
10. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
11. Chen Y., Klionsky D.J. The regulation of autophagy - unanswered questions. J. Cell Sci. 2011, 124:161-170.
12. Wirawan E., et al. Autophagy: for better or for worse. Cell Res. 2012, 22:43-61.
13. Liang J., et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 2007, 9:218-224.
14. Sakaki K., et al. Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum. J. Biol. Chem. 2008, 283:15370-15380.
15. Zhang H., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892-10903.
16. Yu L., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
17. Qu X., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
18. Liang C., et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
19. Takahashi Y., et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 2007, 9:1142-1151.
20. Yue Z., et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15077-15082.
21. Takamura A., et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011, 25:795-800.
22. Futreal P.A., et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 1992, 52:2624-2627.
23. Tangir J., et al. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996, 56:2501-2505.
24. Gao X., et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res. 1995, 55:1002-1005.
25. Liu J., et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011, 147:223-234.
26. Zhou S., et al. The effects of Nrf2 on tumor angiogenesis: a review of the possible mechanisms of action. Crit. Rev. Eukaryot. Gene Expr. 2012, 22:149-160.
27. Garg A.D., et al. ER stress-induced inflammation: does it aid or impede disease progression?. Trends Mol. Med. 2012, 18:589-598.
28. Puissant A., et al. When autophagy meets cancer through p62/SQSTM1. Am. J. Cancer Res. 2012, 2:397-413.
29. Moscat J., Diaz-Meco M.T. p62: a versatile multitasker takes on cancer. Trends Biochem. Sci. 2012, 37:230-236.
30. Duran A., et al. The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis. Cancer Cell 2008, 13:343-354.
31. Hart L.S., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J. Clin. Invest. 2012, 122:4621-4634.
32. Young A.R., et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23:798-803.
33. Lum J.J., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
34. Yang S., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011, 25:717-729.
35. Guo J.Y., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
36. Lock R., et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 2011, 22:165-178.
37. Wu S.Y., et al. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation. Neoplasia 2011, 13:1171-1182.
38. Jones S., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
39. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
40. Kang T.W., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011, 479:547-551.
41. Fung C., et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 2008, 19:797-806.
42. Ma X.H., et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin. Cancer Res. 2011, 17:3478-3489.
43. Lazova R., et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin. Cancer Res. 2012, 18:370-379.
44. Lv Q., et al. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res. 2012, 72:3238-3250.
45. Lu Z., et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Invest. 2008, 118:3917-3929.
46. Elgendy M., et al. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 2011, 42:23-35.
47. Pietras K., Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 2010, 316:1324-1331.
48. Michaud M., et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011, 334:1573-1577.
49. Garg A.D., et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim. Biophys. Acta 2010, 1805:53-71.
50. Dupont N., et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 2011, 30:4701-4711.
51. Townsend K.N., et al. Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity. Immunol. Rev. 2012, 249:176-194.
52. Kuballa P., et al. Autophagy and the immune system. Annu. Rev. Immunol. 2012, 30:611-646.
53. Levine B., et al. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
54. Nakahira K., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
55. Du J., et al. Role of autophagy in angiogenesis in aortic endothelial cells. Am. J. Physiol. Cell Physiol. 2012, 302:C383-C391.
56. Sachdev U., et al. High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury. J. Vasc. Surg. 2012, 55:180-191.
57. Kang R., et al. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 2010, 6:1209-1211.
58. Kang R., et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010, 17:666-676.
59. Lee S.J., et al. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy 2011, 7:829-839.
60. Schreiber R.D., et al. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
61. Narita M., et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011, 332:966-970.
62. Connell P.P., Weichselbaum R.R. A downside to apoptosis in cancer therapy?. Nat. Med. 2011, 17:780-782.
63. Noman M.Z., et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 2011, 71:5976-5986.
64. Garg A.D., et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 2013, (in press).
65. Senovilla L., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012, 337:1678-1684.
66. Verfaillie T., et al. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett. 2013, 332:249-264.
67. De Bock K., et al. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?. Nat. Rev. Clin. Oncol. 2011, 8:393-404.
68. Martinez-Outschoorn U.E., et al. Cancer cells metabolically 'fertilize' the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011, 10:2504-2520.
69. Capparelli C., et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 2012, 11:2285-2302.
70. Martinez-Outschoorn U.E., et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int. J. Biochem. Cell Biol. 2011, 43:1045-1051.
71. Marino M.L., et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J. Biol. Chem. 2012, 287:30664-30676.
72. Tomic T., et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011, 2:e199.
73. Shi W.Y., et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 2012, 3:e275.
74. Blagosklonny M.V. Prevention of cancer by inhibiting aging. Cancer Biol. Ther. 2008, 7:1520-1524.
75. Singletary K., Milner J. Diet, autophagy, and cancer: a review. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1596-1610.
76. Fleming A., et al. Chemical modulators of autophagy as biological probes and potential therapeutics. Nat. Chem. Biol. 2011, 7:9-17.
77. Steeves M.A., et al. Targeting the autophagy pathway for cancer chemoprevention. Curr. Opin. Cell Biol. 2010, 22:218-225.
78. Dunlap S.M., et al. Moderate calorie restriction activates autophagy during tumor growth suppression. Cancer Res. 2012, 72:4104.
79. Shen S., et al. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 2011, 30:4544-4556.
80. Yee K.S., et al. PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ. 2009, 16:1135-1145.
81. Wirawan E., et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010, 1:e18.
82. Lepine S., et al. Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. J. Biol. Chem. 2011, 286:44380-44390.
83. Pagliarini V., et al. Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response. Cell Death Differ. 2012, 19:1495-1504.
84. Oral O., et al. Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death. Apoptosis 2012, 17:810-820.
85. Betin V.M., Lane J.D. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J. Cell Sci. 2009, 122:2554-2566.
86. Ruck A., et al. The Atg6/Vps30/Beclin 1 ortholog BEC-1 mediates endocytic retrograde transport in addition to autophagy in C. elegans. Autophagy 2011, 7:386-400.
87. Yin X., et al. A critical role for UVRAG in apoptosis. Autophagy 2011, 7:1242-1244.
88. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
89. Amaravadi R.K., et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
90. Maclean K.H., et al. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J. Clin. Invest. 2008, 118:79-88.
91. Jiang P.D., et al. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed. Pharmacother. 2010, 64:609-614.
92. Levy J.M., Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol. Ther. 2011, 131:130-141.
93. Briceno E., et al. Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg. Neurol. 2007, 67:388-391.
94. Amaravadi R.K. Cancer. Autophagy in tumor immunity. Science 2011, 334:1501-1502.
95. Maycotte P., et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 2012, 8:200-212.
96. Lee S.J., et al. Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2011, 183:649-658.
97. Hagihara N., et al. Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107. Cancer Res. 2000, 60:230-234.
98. Rouschop K.M., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 2010, 120:127-141.
99. Liang X., et al. Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Res. 2012, 72:2791-2801.
100. Krysko D.V., et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 2012, 12:860-875.
101. Galluzzi L., et al. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J. 2012, 31:1055-1057.
102. Garg A.D., et al. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012, 1:786-788.
103. Dudek A.M., et al. Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev. 2013, 10.1016/j.cytogfr.2013.01.005.
104. Obeid M., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 2007, 13:54-61.
105. Garg A.D., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 2012, 31:1062-1079.
106. Garg A.D., et al. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother. 2012, 61:215-221.
107. Ghiringhelli F., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors. Nat. Med. 2009, 15:1170-1178.
108. Apetoh L., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13:1050-1059.
109. Thorburn J., et al. Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ. 2009, 16:175-183.
110. Li X., Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1α and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res. 2010, 70:5942-5952.
111. Fung C., et al. EGFR tyrosine kinase inhibition induces autophagy in cancer cells. Cancer Biol. Ther. 2012, 13:1417-1424.
112. Garrido G., et al. T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies. Cancer Immunol. Immunother. 2007, 56:1701-1710.
113. Menger L., et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci. Transl. Med. 2012, 4:143ra199.
114. Yang H., et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 2012, 18:250-259.
115. Fader C.M., et al. ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner. Autophagy 2012, 8:1741-1756.
116. Li Y., et al. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 2008, 68:6889-6895.
117. + T cells. Cell Death Differ. 2009, 16:991-1005.
118. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22:407-417.
119. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
120. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013, 20:31-42.
121. Li W.W., et al. Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 2012, 69:1125-1136.
122. Apel A., et al. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008, 68:1485-1494.
123. Lomonaco S.L., et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int. J. Cancer 2009, 125:717-722.
124. Kanzawa T., et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11:448-457.
125. Claerhout S., et al. Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma. Int. J. Cancer 2010, 127:2790-2803.
126. Liu D., et al. Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med. Oncol. 2011, 28:105-111.
127. Rubio N., et al. Spatiotemporal autophagic degradation of oxidatively damaged organelles after photodynamic stress is amplified by mitochondrial reactive oxygen species. Autophagy 2012, 8:1312-1324.
128. Dewaele M., et al. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J. Cell. Mol. Med. 2011, 15:1402-1414.
129. Kessel D.H., et al. ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage. Autophagy 2012, 8:1333-1341.
130. Chen Y., et al. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15:171-182.
131. Samaddar J.S., et al. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol. Cancer Ther. 2008, 7:2977-2987.
132. Li M., et al. Autophagy protects LNCaP cells under androgen deprivation conditions. Autophagy 2008, 4:54-60.
133. Shingu T., et al. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int. J. Cancer 2009, 124:1060-1071.
134. Bellodi C., et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 2009, 119:1109-1123.
135. Crowley L.C., et al. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am. J. Hematol. 2011, 86:38-47.
136. Gupta A., et al. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14333-14338.
137. Wu Z., et al. Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer 2010, 1:40-49.
138. Wang K., et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy 2011, 7:966-978.
139. Milani M., et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 2009, 69:4415-4423.
140. Kawaguchi T., et al. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. Int. J. Oncol. 2011, 38:643-654.
141. Iwamaru A., et al. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene 2007, 26:1840-1851.
142. Vazquez-Martin A., et al. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS ONE 2009, 4:e6251.
143. Carew J.S., et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007, 110:313-322.
144. Li J., et al. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur. J. Cancer 2010, 46:1900-1909.
145. Tiwari M., et al. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 2008, 29:600-609.
146. Kanematsu S., et al. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res. 2010, 30:3381-3390.
147. Nishikawa T., et al. Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann. Surg. Oncol. 2010, 17:592-602.
148. Tormo D., et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 2009, 16:103-114.
149. Kim R.H., et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009, 69:700-708.
150. Bommareddy A., et al. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res. 2009, 69:3704-3712.
151. Suh Y., et al. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis 2010, 31:1424-1433.
152. Puissant A., et al. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 2010, 70:1042-1052.
153. Kim E.H., et al. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res. 2007, 67:6314-6324.
154. Aoki H., et al. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 2007, 72:29-39.
155. Hoyer-Hansen M., et al. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 2005, 12:1297-1309.
156. Salazar M., et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 2009, 119:1359-1372.
157. Park E.J., et al. β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem. Biol. Interact. 2011, 189:37-44.
158. Ling Y.H., et al. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase. Clin. Cancer Res. 2011, 17:5353-5366.
159. Inoue S., et al. Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin. Pigment Cell Res. 1993, 6:354-358.
160. Bettuzzi S., et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
161. Wilken R., et al. Curcumin: a review of anticancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 2011, 10:12.
162. Singh M., et al. New strategies in cancer chemoprevention by phytochemicals. Front. Biosci. (Elite Ed.) 2012, 4:426-452.